Please click on the link that has been just sent to [email] in order to verify your email and proceed to browse investment opportunities
Resend confirmation link
Three global PE investment firms, Bain Capital, Blackstone and KKR, have expressed interest in acquiring a majority stake in pharmaceutical manufacturing company, Granules India.
Reportedly, the Indian firm is evaluating the sale of a controlling stake at a premium valuation and the three leading PE firms have submitted non-binding bids.
Granules India is recognised as one of the world’s top makers of the popular fever reliever pills – paracetamol.
Source: Money Control
Moonfare gives you access to the top 5% of funds we review. Our clients have trusted us to invest over €500 million.
Sign Up
